Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal

Current Opinion in Cell Biology

Volumn 6, Issue 6, 1994, Pages 788-794

  Lassar, Andrew B ^a   Skapek, Stephen X ^a   Novitch, Bennett ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; GROWTH FACTOR; MYOGENIN; ONCOPROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; CELL CYCLE; CELL DIFFERENTIATION; EMBRYO; GENE EXPRESSION; GENE EXPRESSION REGULATION; MITOSIS INHIBITION; MOUSE; MUSCLE DEVELOPMENT; MUSCLE FIBER CULTURE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RHABDOMYOSARCOMA; SKELETAL MUSCLE; TUMOR SUPPRESSOR GENE;

ANIMAL; CELL CYCLE; CELL DIFFERENTIATION; HELIX-LOOP-HELIX MOTIFS; MUSCLE, SKELETAL; MYOD PROTEIN; ONCOGENE PROTEINS; RHABDOMYOSARCOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

ANIMALIA;

EID: 0028032677     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0955-0674(94)90046-9     Document Type: Article

References (54)

1. Skeletal myogenesis: genetics and embryology to the fore
2. Myogenic regulatory factors: dissecting their role and regulation during vertebrate embryogenesis
3. The MyoD family and myogenesis: redundancy, networks, and thresholds
4. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis
5. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out
6. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo
7. The myogenic helix-loop-helix family: regulators of skeletal muscle determination and differentiation
8. The MyoD gene family: nodal point during specification of the muscle cell lineage
9. Skeletal muscle phenotypes initiated by ectopic MyoD in transgenic mouse heart
10. Expression of bovine Myf5 induces ectopic skeletal muscle formation in transgenic mice
11. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains
12. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain
13. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins
14. Multiple oligometric states regulate the DNA binding of helix-loop-helix peptides
15. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins
16. HLH forced dimers: tethering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id
17. An E box mediates activation and repression of the acetylcholine receptor δ-subunit gene during myogenesis
18. Functional antagonism between c-Jun and MyoD proteins: a direct physical association
19. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression
20. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators
21. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation
22. Cis-4-hydroxy-L-proline and ethyl-3,4-dihydroxybenzoate prevent myogenesis of C2C12 muscle cells and block MyoD1 and myogenin expression
23. ‘Spontaneous’ differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II
24. Muscle differentiation: insulin-like growth factors as positive modulators of myogenic regulatory genes?
25. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and the type 1 IGF receptor (Ifg1r)
26. IGF-I is required for normal embryonic growth in mice
27. Transforming growth factor-β represses the actions of myogenin through a mechanism independent of DNA binding
28. Differential response of embryonic and fetal myoblasts to TGFβ: a possible regulatory mechanism of skeletal muscle histogenesis
29. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-β receptor
30. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12
31. Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation
32. Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro
33. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
34. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen
35. MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein
36. Reversal of terminal differentiation and control of DNA replication: cyclin A and cdk2 specifically localize at subnuclear sites of DNA replication
37. SV40 large T inhibits myogenic differentiation partially through inducing c-jun
38. Inhibition of muscle differentiation by the adenovirus E1A protein: repression of the transcriptional activating function of the HLH protein Myf-5
39. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein
40. 3H1 myoblasts correlates with their binding to a 300 kDa cellular protein
41. 125 and basic helix-loop-helix proteins
42. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor
43. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators
44. Reversal of terminal differentiation mediated by p107 in Rb -/- muscle cells
45. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis
46. Induction of cell differentiation by human immunodeficiency virus 1 vpr
47. Cell surface fibroblast growth factor and epidermal growth factor receptors are permanently lost during skeletal muscle terminal differentiation in culture
48. Heterokaryon analysis of muscle differentiation: regulation of the postmitotic state
49. Repression of c-fos promoter by MyoD on muscle cell differentiation
50. Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation
51. Tumor suppression by RNA from the 3′ untranslated region of α-tropomyosin
52. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins
53. DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control
54. Reversal of muscle differentiation during urodele limb regeneration